Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $25,875,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Thursday, August 20th, J.H. Whitney Equity Partners V sold 12,496,077 shares of Aveanna Healthcare stock. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50.
• On Tuesday, June 30th, J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35.
• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total value of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Price Performance

AVAH traded up $0.54 during trading on Monday, reaching $13.70. 5,371,630 shares of the company traded hands, compared to its average volume of 1,804,159. The company has a market cap of $2.99 billion, a P/E ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.98. The firm has a fifty day simple moving average of $9.58 and a 200 day simple moving average of $7.92.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Analyst Ratings Changes

AVAH has been the subject of a number of research analyst reports. Raymond James Financial raised their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research report on Friday, August 14th. BMO Capital Markets increased their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Truist Financial lifted their price objective on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday. Finally, Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.89.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System lifted its stake in shares of Aveanna Healthcare by 1,351.3% in the 2nd quarter. California State Teachers Retirement System now owns 730,027 shares of the company’s stock valued at $6,256,000 after purchasing an additional 679,727 shares during the last quarter. Braidwell LP increased its position in shares of Aveanna Healthcare by 39.1% during the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after purchasing an additional 861,600 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Aveanna Healthcare by 17.6% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company’s stock valued at $831,000 after purchasing an additional 14,492 shares during the last quarter. Littlejohn & Co. LLC purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at $1,846,878,000. Finally, Corient Private Wealth LP purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at $176,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.